Lapkina-Gendler L - Search Results

1

Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action.

Nagaraj K, Lapkina-Gendler L, Sarfstein R, Gurwitz D, Pasmanik-Chor M, Laron Z, Yakar S, Werner H. Nagaraj K, et al. Among authors: lapkina gendler l. Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1045-1050. doi: 10.1073/pnas.1715930115. Epub 2018 Jan 16. Proc Natl Acad Sci U S A. 2018. PMID: 29339473 Free PMC article.

2

Identification of signaling pathways associated with cancer protection in Laron syndrome.

Lapkina-Gendler L, Rotem I, Pasmanik-Chor M, Gurwitz D, Sarfstein R, Laron Z, Werner H. Lapkina-Gendler L, et al. Endocr Relat Cancer. 2016 May;23(5):399-410. doi: 10.1530/ERC-16-0054. Epub 2016 Apr 18. Endocr Relat Cancer. 2016. PMID: 27090428

3

Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence.

Somri L, Sarfstein R, Lapkina-Gendler L, Nagaraj K, Laron Z, Bach LA, Werner H. Somri L, et al. Among authors: lapkina gendler l. Growth Horm IGF Res. 2018 Apr;39:6-12. doi: 10.1016/j.ghir.2017.11.004. Epub 2017 Nov 24. Growth Horm IGF Res. 2018. PMID: 29208357

4

Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways.

Werner H, Lapkina-Gendler L, Achlaug L, Nagaraj K, Somri L, Yaron-Saminsky D, Pasmanik-Chor M, Sarfstein R, Laron Z, Yakar S. Werner H, et al. Among authors: lapkina gendler l. Cells. 2019 Jun 15;8(6):596. doi: 10.3390/cells8060596. Cells. 2019. PMID: 31208077 Free PMC article. Review.

5

Identification of nephronectin as a new target for IGF1 action.

Sarfstein R, Lapkina-Gendler L, Nagaraj K, Laron Z, Werner H. Sarfstein R, et al. Among authors: lapkina gendler l. Eur J Cancer. 2020 Dec;141:115-127. doi: 10.1016/j.ejca.2020.09.034. Epub 2020 Oct 30. Eur J Cancer. 2020. PMID: 33130549

6

The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.

Shibel R, Sarfstein R, Nagaraj K, Lapkina-Gendler L, Laron Z, Dixit M, Yakar S, Werner H. Shibel R, et al. Among authors: lapkina gendler l. Cells. 2021 Jun 12;10(6):1483. doi: 10.3390/cells10061483. Cells. 2021. PMID: 34204736 Free PMC article.

7

Fifty years on: New lessons from Laron syndrome.

Werner H, Lapkina-Gendler L, Laron Z. Werner H, et al. Among authors: lapkina gendler l. Isr Med Assoc J. 2017 Jan;19(1):6-7. Isr Med Assoc J. 2017. PMID: 28457105 Free article. No abstract available.

8

Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer.

Achlaug L, Sarfstein R, Nagaraj K, Lapkina-Gendler L, Bruchim I, Dixit M, Laron Z, Yakar S, Werner H. Achlaug L, et al. Among authors: lapkina gendler l. Oncotarget. 2019 Jul 9;10(43):4437-4448. doi: 10.18632/oncotarget.27055. eCollection 2019 Jul 9. Oncotarget. 2019. PMID: 31320996 Free PMC article.

9

Erratum to 'Identification of nephronectin as a new target for IGF1 action' [Eur J Canc 141 (2020) Pages 115-127].

Sarfstein R, Lapkina-Gendler L, Nagaraj K, Laron Z, Werner H. Sarfstein R, et al. Among authors: lapkina gendler l. Eur J Cancer. 2021 May;148:453-454. doi: 10.1016/j.ejca.2021.02.014. Epub 2021 Mar 13. Eur J Cancer. 2021. PMID: 33726998 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters